Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticancer opportunities at every stage of chemokine function
Natalia V. Ortiz Zacarı́as, Martijn P. Bemelmans, Tracy M. Handel, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 11, pp. 912-928
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

How chemokines organize the tumour microenvironment
Thorsten R. Mempel, Julia K. Lill, Lukas M. Altenburger
Nature reviews. Cancer (2023) Vol. 24, Iss. 1, pp. 28-50
Closed Access | Times Cited: 95
CXCL5: A coachman to drive cancer progression
Jie Deng, Rongqi Jiang, Enqing Meng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 41
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine
Hanli Xu, Shuye Lin, Ziyun Zhou, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 7, pp. 739-776
Open Access | Times Cited: 32
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 29
Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics
Saumya Srivastava, Atish Mohanty, Arin Nam, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 233-246
Open Access | Times Cited: 38
Atypical chemokine receptors: emerging therapeutic targets in cancer
Robert J. Torphy, Elliott J. Yee, Richard D. Schulick, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 12, pp. 1085-1097
Open Access | Times Cited: 28
Pharmacological targeting of the tumor–immune symbiosis in glioblastoma
Lizhi Pang, Fatima Khan, Madeline Dunterman, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 8, pp. 686-700
Open Access | Times Cited: 24
Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma
Annette Gilchrist, Stephanie Lourdes Echeverria
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 23
Role of chemokines in breast cancer
Marilyn Masih, Sonam Agarwal, Rupinder Kaur, et al.
Cytokine (2022) Vol. 155, pp. 155909-155909
Closed Access | Times Cited: 21
Structural perspectives on chemokine receptors
Kanwal Kayastha, Yangli Zhou, Steffen Brünle
Biochemical Society Transactions (2024) Vol. 52, Iss. 3, pp. 1011-1024
Open Access | Times Cited: 4
Chemokine family significance and prognostic value in colorectal cancer
Yi Ding, Yinnan Chen, Siyun Xie, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Novel CXCR2 antibodies exhibit enhanced anti-tumor activity in pancreatic cancer
Parastou Rahimizadeh, Se Heon Kim, Bo Hyun Yoon, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117966-117966
Closed Access
Discovery and exploration of disubstituted [1,2,5]oxadiazolo- [3,4-b]pyrazines as novel C-C chemokine receptor type 5 signaling inhibitors targeting the intracellular allosteric binding pocket
Margaux Billen, Sten Reynders, Sandra Claes, et al.
European Journal of Medicinal Chemistry (2025), pp. 117600-117600
Closed Access
Targeting chemokine receptors from the inside-out: discovery and development of small-molecule intracellular antagonists
Margaux Billen, Dominique Schols, Peter Verwilst
Chemical Communications (2022) Vol. 58, Iss. 26, pp. 4132-4148
Open Access | Times Cited: 18
The functional roles of chemokines and chemokine receptors in colorectal cancer progression
Mingli Yue, Mengmeng Chen, Bingqiang Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116040-116040
Open Access | Times Cited: 10
Cancer Immunoediting and beyond in 2021
Elena Monica Borroni, Fabio Grizzi
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13275-13275
Open Access | Times Cited: 21
Identification of GGT5 as a Novel Prognostic Biomarker for Gastric Cancer and its Correlation With Immune Cell Infiltration
Yuli Wang, Yuan Fang, Fanchen Zhao, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 16
Modulating the tumor-associated macrophage landscape
Alexandre Boissonnas, Christophe Combadière
Nature Immunology (2022) Vol. 23, Iss. 4, pp. 481-482
Closed Access | Times Cited: 13
PD-L2 mediates tobacco smoking-induced recruitment of regulatory T cells via the RGMB/NFκB/CCL20 cascade
Hua Guo, Chen Zhang, Yu-Ke Shen, et al.
Cell Biology and Toxicology (2024) Vol. 40, Iss. 1
Open Access | Times Cited: 2
Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme
Yuling Yang, Xing Fu, Runsha Liu, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 5
Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis
Zhou Tian, Baojian Hong, Jianzhong Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
The Chemokine System in Oncogenic Pathways Driven by Viruses: Perspectives for Cancer Immunotherapy
Géraldine Schlecht‐Louf, Claire Deback, Françoise Bachelerie
Cancers (2022) Vol. 14, Iss. 3, pp. 848-848
Open Access | Times Cited: 8
In silico approach to identify novel allosteric intracellular antagonist for blocking the interleukin-8/CXCR2 receptor signaling pathway
Thi-Thuy-Nga Tran, Que-Huong Tran, Cuong Quoc Duong, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 22, pp. 13154-13167
Closed Access | Times Cited: 4
SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis
Fanghua Chen, Ling Aye, Lei Yu, et al.
Carcinogenesis (2023) Vol. 44, Iss. 3, pp. 232-241
Closed Access | Times Cited: 4
Impact of cancer-associated mutations in CC chemokine receptor 2 on receptor function and antagonism
Lisa S. den Hollander, Olivier J. M. Béquignon, Xiangzi Wang, et al.
Biochemical Pharmacology (2022) Vol. 208, pp. 115399-115399
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top